Class II antigen expression by keratinocytes and enterocytes—an early feature of graft-versus-host-disease
L SVILAND, ADJ PEARSON, EJ EASTHAM… - …, 1988 - journals.lww.com
L SVILAND, ADJ PEARSON, EJ EASTHAM, MA GREEN, PJ HAMILTON, SJ PROCTOR…
Transplantation, 1988•journals.lww.compeutic drug monitoring. Spokane: Applied Therapeutics, 1986: Page 1 402 Blood 1985; 66;
698. 3, Yee GC, Kennedy MS. Cyclosporine. In: Evans WE, Schentag JJ, Jusko WJ, eds.
Applied pharmacokinetics: principles of therapeutic drug monitoring. Spokane: Applied
Therapeutics, 1986: R28. 4. Yee GC, Lennon TP, Gmur DJ, Kennedy MS, Deeg HJ Agedependent
cyclosporine pharmacokinetics in marrow transplant recipients. Clin Pharmacol Ther 1986; 40:
438. 5. Ptachcinski RJ, Venkataramanan R, Rosenthal JT, Burckart GJ, Taylor RJ, Hakala TR …
698. 3, Yee GC, Kennedy MS. Cyclosporine. In: Evans WE, Schentag JJ, Jusko WJ, eds.
Applied pharmacokinetics: principles of therapeutic drug monitoring. Spokane: Applied
Therapeutics, 1986: R28. 4. Yee GC, Lennon TP, Gmur DJ, Kennedy MS, Deeg HJ Agedependent
cyclosporine pharmacokinetics in marrow transplant recipients. Clin Pharmacol Ther 1986; 40:
438. 5. Ptachcinski RJ, Venkataramanan R, Rosenthal JT, Burckart GJ, Taylor RJ, Hakala TR …
Abstract
HLA-DR expression by keratinocytes and enterocytes was studied in 23 patients undergoing BMT (12 autologous; 11 allogeneic). Two monoclonal antibodies were used to detect the HLA-DR antigen.
Lippincott Williams & Wilkins